Helen Denley
- Cancer Research top 5%
- Breast Cancer Treatment Studies 10
- Cancer, Hypoxia, and Metabolism 8
- Cancer-related molecular mechanisms research 4
-
- Breast Lesions and Carcinomas 8
- Oncology top 10%
- Dermatology top 5%
- Cancer and Skin Lesions 4
-
- Bladder and Urothelial Cancer Treatments 5
- Urinary and Genital Oncology Studies 3
-
- RNA modifications and cancer 4
- Co-authors
- Ian O. EllisSarah E. PinderAndrew EvansCatharine WestPeter HoskinJ F MayberryJoely J. IrlamJayne Eaden
- Partner nations
- United KingdomEgyptAustralia
In The Last Decade
Helen Denley
38 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 84
- Cancer Research 541
- Pathology and Forensic Medicine 320
- Oncology 416
- Radiology, Nuclear Medicine and Imaging 274
- Dermatology 84
Countries citing papers authored by Helen Denley
This map shows the geographic impact of Helen Denley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Denley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Denley more than expected).
Fields of papers citing papers by Helen Denley
This network shows the impact of papers produced by Helen Denley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Denley. The network helps show where Helen Denley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen Denley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 89 | |
| 2 | 2017 | 8 | |
| 3 | Management of Recurrent aHUS After Adult Kidney transplantation Despite Eculizumab Prophylaxis. | 2016 | 0 |
| 4 | 2016 | 47 | |
| 5 | 2014 | 34 | |
| 6 | 2013 | 167 | |
| 7 | 2013 | 23 | |
| 8 | 2012 | 39 | |
| 9 | 2011 | 13 | |
| 10 | 2007 | 3 | |
| 11 | 2004 | 26 | |
| 12 | 2004 | 18 | |
| 13 | 2003 | 80 | |
| 14 | 2003 | 108 | |
| 15 | 2001 | 19 | |
| 16 | 2001 | 157 | |
| 17 | 2001 | 58 | |
| 18 | 1999 | 9 | |
| 19 | 1999 | 3 | |
| 20 | 1998 | 12 |
About Helen Denley
Helen Denley is a scholar working on Cancer Research, Microbiology and Pathology and Forensic Medicine, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (8 papers), Cancer, Hypoxia, and Metabolism (8 papers), Bladder and Urothelial Cancer Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer and Skin Lesions (4 papers), RNA modifications and cancer (4 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Cancer Research (541 citations), Pathology and Forensic Medicine (320 citations) and Oncology (416 citations). Helen Denley has collaborated with scholars based in United Kingdom, Egypt and Australia. Frequent co-authors include Ian O. Ellis, Sarah E. Pinder, Andrew Evans, Catharine West, Peter Hoskin, J F Mayberry, Joely J. Irlam, Jayne Eaden, H. A. McKay and Keith R. Abrams. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.